Great news – The Eastern District Hospital has acquired 2 single-person HBOT chambers to meet growing patients demand!
As reported by RTHK news, the “first in-hospital hyperbaric oxygen therapy centre in Hong Kong located at Pamela Youde Nethersole Hospital in the Eastern District has been in use for more than 4 years. The multi-person treatment chamber in use can only serve twice a day, and the waiting time for hyperbaric oxygen therapy patients is as long as one year. The Eastern District Hospital then introduced two single-person treatment chambers, mainly for the treatment of stable chronic diseases and isolation treatment for patients with infectious diseases.”
When applied as a medical treatment, “hyperbaric oxygen therapy refers to allowing patients to enter a treatment chamber with a pressure higher than normal atmospheric pressure to receive 100% pure oxygen therapy to reduce the air bubbles in the body and increase the partial pressure of oxygen in body tissues, thereby eliminating vascular air bubble blockage, promoting vascular proliferation, and improving white blood cells function, reduce oedema, antibacterial, and promote osteoblast formation.”
Dr. Yan Wing Wa (殷榮華醫生), Consultant Doctor of Hyperbaric Oxygen Therapy Centre, “pointed out that the hyperbaric oxygen therapy chamber is most commonly used to treat carbon monoxide poisoning, accounting for 40% of the total use, followed by trauma after radiation therapy, accounting for 19%, and central retinal artery occlusion, commonly known as “eye stroke”, accounts for about 16%.”
東區醫院增兩高壓氧治療單人艙
“位於東區尤德夫人那打素醫院的全港首個駐院高壓氧治療中心啟用超過4年，正使用的多人治療艙每日只能服務兩次，等候高壓氧治療病人輪候時間長達一年。東區醫院遂引入兩個單人治療艙，主要用於治療穩定的慢性病症以及為患傳染性疾病病人作隔離治療。”
“東區醫院是全港首間提供高壓氧治療的醫院，這項治療技術是病人透過在高於大氣壓力的治療艙內聞純氧，從而縮小體內氣泡，達致消除血管氣泡阻塞、改善白血球功能、減少水腫等，用於腦動脈氣體栓塞等危重疾病、放射性治療後發創傷等慢性疾病，甚至治療部分緊急病症，例如突發性失明、失聰等。”
“中心顧問醫生殷榮華表示，高壓氧治療艙最常用於治療一氧化碳中毒，佔整體使用的40%，其次為放射性治療後發創傷，佔19%，而俗稱「眼中風」的中心視網膜動脈阻塞則佔約16%。”
Sources:
https://news.rthk.hk/rthk/ch/component/k2/1700477-20230514.htm
https://www.ha.org.hk/haho/ho/cc/271005ee.pdf
https://bit.ly/3COD0N9